No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors*
-
B7-H1 Antigen / immunology
-
BRCA2 Protein / genetics*
-
Carcinoma / drug therapy*
-
Carcinoma / genetics
-
Carcinoma / immunology
-
Carcinoma / secondary
-
Cystectomy
-
Disease Progression
-
Drug Substitution
-
Humans
-
Male
-
Middle Aged
-
Molecular Diagnostic Techniques
-
Molecular Targeted Therapy
-
Phthalazines / therapeutic use*
-
Piperazines / therapeutic use*
-
Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use*
-
Positron Emission Tomography Computed Tomography
-
Treatment Outcome
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / genetics
-
Urinary Bladder Neoplasms / immunology
-
Urinary Bladder Neoplasms / pathology
-
Urothelium / drug effects*
-
Urothelium / immunology
-
Urothelium / pathology
-
Urothelium / surgery
Substances
-
Antineoplastic Agents, Immunological
-
B7-H1 Antigen
-
BRCA2 Protein
-
BRCA2 protein, human
-
CD274 protein, human
-
Phthalazines
-
Piperazines
-
Poly(ADP-ribose) Polymerase Inhibitors
-
olaparib